{"id":"https://openalex.org/W753836199","doi":null,"title":"Design, Synthesis and Evaluation of 1,3,2 Diazaphosphorin[4,5-b]Quinoxaline-5,10-di-N-oxide Derivatives as Novel VEGFR-2 and SRCKinase Inhibitors in the Treatment of Prostate Cancer","display_name":"Design, Synthesis and Evaluation of 1,3,2 Diazaphosphorin[4,5-b]Quinoxaline-5,10-di-N-oxide Derivatives as Novel VEGFR-2 and SRCKinase Inhibitors in the Treatment of Prostate Cancer","publication_year":2013,"publication_date":"2013-10-30","ids":{"openalex":"https://openalex.org/W753836199","mag":"753836199"},"language":"en","primary_location":{"id":"mag:753836199","doi":null,"is_oa":false,"landing_page_url":"https://benthamopen.com/ABSTRACT/TOPROCJ-4-3-77","pdf_url":null,"source":{"id":"https://openalex.org/S4210218112","display_name":"The Open Conference Proceedings Journal","issn_l":"2210-2892","issn":["2210-2892"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"conference"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The Open Conference Proceedings Journal","raw_type":null},"volume":null,"type":"conference-paper","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044505549","display_name":"Abdel\u2010Sattar S. Hamad Elgazwy","orcid":"https://orcid.org/0000-0002-7948-2430","observed_orcids":["https://orcid.org/0000-0002-7948-2430"]},"institutions":[{"id":"https://openalex.org/I4403928277","display_name":"Bentham Science Publishers (United Arab Emirates)","ror":"https://ror.org/01866ja76","country_code":"AE","type":"company","lineage":["https://openalex.org/I4403928277"]}],"countries":["AE"],"is_corresponding":false,"raw_author_name":"Abdel\u2010Sattar S. Hamad Elgazwy","raw_affiliation_strings":["Bentham Science Publishers"],"raw_orcid":"https://orcid.org/0000-0002-7948-2430","affiliations":[{"raw_affiliation_string":"Bentham Science Publishers","institution_ids":["https://openalex.org/I4403928277"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113558611","display_name":"Dalia Hussein Soliman","orcid":"https://orcid.org/0000-0002-1541-8165","observed_orcids":["https://orcid.org/0000-0002-1541-8165"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dalia H. Soliman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.07021467,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"4","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","score":0.9291999936103821,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","score":0.9291999936103821,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.035599999129772186,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11748","display_name":"Organophosphorus compounds synthesis","score":0.015799999237060547,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/src-inhibitors","display_name":"Src kinase inhibitor","score":0.9890000224113464},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7879999876022339},{"id":"https://openalex.org/keywords/pc-3-cells","display_name":"PC-3 cells","score":0.800000011920929},{"id":"https://openalex.org/keywords/phosphorus-heterocycles","display_name":"phosphorus heterocycles","score":0.7480000257492065},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.6869999766349792},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7584905028343201},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.6550440788269043},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6357913017272949},{"id":"https://openalex.org/C2780362310","wikidata":"https://www.wikidata.org/wiki/Q419930","display_name":"Quinoxaline","level":2,"score":0.6289815902709961},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.5586070418357849},{"id":"https://openalex.org/C108636557","wikidata":"https://www.wikidata.org/wiki/Q21109354","display_name":"Proto-oncogene tyrosine-protein kinase Src","level":3,"score":0.5215280055999756},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49589499831199646},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.49385005235671997},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.4700535535812378},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.42478129267692566},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40498191118240356},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3648502826690674},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.33035770058631897},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3201014995574951},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.28294306993484497},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21969351172447205},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1863359808921814},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.10723811388015747},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.055261194705963135},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:753836199","doi":null,"is_oa":false,"landing_page_url":"https://benthamopen.com/ABSTRACT/TOPROCJ-4-3-77","pdf_url":null,"source":{"id":"https://openalex.org/S4210218112","display_name":"The Open Conference Proceedings Journal","issn_l":"2210-2892","issn":["2210-2892"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"conference"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The Open Conference Proceedings Journal","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W189716430","https://openalex.org/W1854708637","https://openalex.org/W1967232244","https://openalex.org/W1970308983","https://openalex.org/W1978796960","https://openalex.org/W1982317652","https://openalex.org/W1983225862","https://openalex.org/W1987079567","https://openalex.org/W1991541715","https://openalex.org/W1999966784","https://openalex.org/W2000000541","https://openalex.org/W2000292756","https://openalex.org/W2003049579","https://openalex.org/W2006285052","https://openalex.org/W2014604539","https://openalex.org/W2023103815","https://openalex.org/W2027511653","https://openalex.org/W2032116260","https://openalex.org/W2053117355","https://openalex.org/W2054241501","https://openalex.org/W2056676856","https://openalex.org/W2064203668","https://openalex.org/W2064991073","https://openalex.org/W2080439368","https://openalex.org/W2080899558","https://openalex.org/W2084630618","https://openalex.org/W2088754918","https://openalex.org/W2095804889","https://openalex.org/W2104079713","https://openalex.org/W2109689528","https://openalex.org/W2111631361","https://openalex.org/W2118999256","https://openalex.org/W2120292596","https://openalex.org/W2123526148","https://openalex.org/W2125752165","https://openalex.org/W2127988517","https://openalex.org/W2144429930","https://openalex.org/W2144502394","https://openalex.org/W2151619877","https://openalex.org/W2152105694","https://openalex.org/W2157760009","https://openalex.org/W2160112381","https://openalex.org/W2161240269","https://openalex.org/W2290659590","https://openalex.org/W2402465348","https://openalex.org/W2476572578","https://openalex.org/W2949412156","https://openalex.org/W2949618568","https://openalex.org/W2951072844"],"related_works":["https://openalex.org/W7100865152","https://openalex.org/W2020003389","https://openalex.org/W3196617292","https://openalex.org/W4383738988","https://openalex.org/W2098429463","https://openalex.org/W3103854394","https://openalex.org/W3096002562","https://openalex.org/W4415330480","https://openalex.org/W2084630618","https://openalex.org/W3126486277"],"abstract_inverted_index":{"Prostate":[0],"cancer":[1,17,38,85],"remains":[2],"a":[3,52,56],"significant":[4],"public":[5],"health":[6],"problem,":[7],"with":[8,104,131],"limited":[9],"therapeutic":[10],"options.":[11],"Recently,":[12],"new":[13,42,68,76,115],"approaches":[14],"in":[15,32,51],"prostate":[16,37,84],"treatment":[18],"have":[19],"been":[20],"developed,":[21],"inhibition":[22],"of":[23,36,44,59,62,66,113,160],"the":[24,60,67,100,114,128,135,144],"proangiogenic":[25],"VEGFR":[26],"kinase":[27],"and":[28,34,91,108,120],"SRC":[29,121,147],"kinase,":[30],"involved":[31],"progression":[33],"metastasis":[35],"were":[39,79],"investigated.":[40],"A":[41],"series":[43],"1,3,2diazaphosphorin(4,5-b)quinoxaline-5,10-di-N-oxide":[45],"was":[46,70,127,141,151],"synthesized":[47,77,116],"using":[48],"Lawson's":[49],"reagent":[50],"reaction":[53],"that":[54,124],"provides":[55],"rare":[57],"example":[58],"incorporation":[61],"phosphorous.":[63],"The":[64,75],"structure":[65],"compounds":[69,78,117,145],"confirmed":[71],"by":[72,143],"spectroscopic":[73],"data.":[74],"evaluated":[80],"for":[81,153],"their":[82],"in-vitro":[83],"cell":[86],"line":[87],"(PC3).":[88],"Compounds":[89],"7a":[90,126,155],"8a":[92],"possessed":[93],"remarkable":[94],"antitumor":[95],"activity":[96],"more":[97],"active":[98],"than":[99],"known":[101],"drug":[102],"Doxorubicin":[103],"IC50=":[105,132],"0.12,":[106],"0.36":[107],"0.63":[109],"\u00b5M":[110],"respectively.":[111],"Evaluation":[112],"on":[118,146],"VEGFR-2":[119,161],"kinases":[122],"showed":[123],"compound":[125,154],"most":[129],"effective":[130],"18\u00b5M.":[133],"On":[134],"other":[136],"hand,":[137],"weak":[138],"inhibitory":[139],"effect":[140],"observed":[142],"kinase.":[148,162],"Docking":[149],"study":[150],"performed":[152],"into":[156],"ATP":[157],"binding":[158],"site":[159]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}